Chronic anisakiasis presenting as a mesenteric mass

2000 ◽  
Vol 25 (5) ◽  
pp. 548-550 ◽  
Author(s):  
M. Céspedes ◽  
A. Saez ◽  
I. Rodríguez ◽  
J. M. Pinto ◽  
R. Rodríguez
Keyword(s):  
Mesenteric Mass

scholarly journals Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours

Cancers ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 443
Author(s):  
Anela Blažević ◽  
Tessa Brabander ◽  
Wouter T. Zandee ◽  
Johannes Hofland ◽  
Gaston J. H. Franssen ◽  
...  
Keyword(s):  
Neuroendocrine Tumours ◽  
Peptide Receptor Radionuclide Therapy ◽  
Size Reduction ◽  
Static Behavior ◽  
Recist 1.1 ◽  
Mesenteric Mass ◽  
Small Intestinal ◽  
Objective Size ◽  
Over Time

Background: A metastatic mesenteric mass is a hallmark of small intestinal neuroendocrine tumours (SI-NETs). However, little is known on its development over time. Therefore, we conducted a study to assess the evolution of a SI-NET-associated mesenteric mass over time. Methods: Retrospectively, 530 patients with proven SI-NET were included. The presence and growth of a mesenteric mass was assessed using RECIST 1.1 criteria on every consecutive CT-scan until the end of follow-up or resection. Results: At baseline, a mesenteric mass was present in 64% of the patients, of whom 13.5% showed growth of the mesenteric mass with a median time to growth of 40 months. Male gender was the only independent predictor of growth (OR 2.67). Of the patients without a mesenteric mass at the first evaluation, 2.6% developed a pathological mesenteric mass. Treatment with peptide receptor radionuclide therapy (PRRT; N = 132) resulted in an objective size reduction of the mesenteric mass in 3.8%. Conclusion: The metastatic mesenteric mass in SI-NETs has a static behavior over time. Therefore, site-specific growth behavior should be taken into account when selecting target lesions and assessing disease progression and therapeutic response. PRRT appears not to be effective for size reduction of the mesenteric mass.

Hematochezia and a Mesenteric Mass

2015 ◽  
Vol 149 (1) ◽  
pp. e12-e13
Author(s):  
Vijaya L. Rao ◽  
Dejan Micic ◽  
David T. Rubin
Keyword(s):  
Mesenteric Mass

scholarly journals Retroperitoneal fibromatosis presenting as a mesenteric mass

Medicine ◽  
2020 ◽  
Vol 99 (17) ◽  
pp. e18799
Author(s):  
Jianchun Xiao ◽  
Wenzhe Zhou
Keyword(s):  
Mesenteric Mass

Rare cystic mesenteric mass of the small bowel: mesenteric lymphangioma

2020 ◽  
Author(s):  
Daniel Ong ◽  
Benjamin Cribb ◽  
Matthew Marshall‐Webb ◽  
Jonathan Yong
Keyword(s):  
Small Bowel ◽  
Mesenteric Lymphangioma ◽  
Mesenteric Mass

scholarly journals Concurrent lymphosarcoma and Salmonella enteritidis infection in a cat: a case report

2009 ◽  
Vol 54 (No. 9) ◽  
pp. 451-454 ◽  
Author(s):  
M.I. Bhaiyat ◽  
H. Hariharan ◽  
A. Chikweto ◽  
E. Brathwaite-Sylvester ◽  
P.J.A. Burnett ◽  
...  
Keyword(s):  
Case Report ◽  
Clinical Examination ◽  
Salmonella Enteritidis ◽  
Thoracic Cavity ◽  
Palpable Mass ◽  
Mesenteric Mass ◽  
History Of ◽  
Gross Lesions ◽  
The Masses ◽  
Susceptibility Patterns

Concurrent lymphosarcoma and salmonellosis in a 12-year-old female neutered domestic shorthair cat in Grenada is described. Clinically, the cat was emaciated, and had a history of vomiting and diarrhea of two months duration. Clinical examination revealed a large palpable mass in the craniodorsal abdomen and fluid in the thoracic cavity. Gross lesions consisted of moderate pyothorax and pyoabdomen with variably-sized, single to multiple, soft, white masses in the mesentery adjacent to the pancreas, on the serosal surface of the stomach, and on the quadrate lobe of the liver. Histopathological findings associated with these masses were compatible with lymphosarcoma. Sheets of neoplastic round cells, some with intracytoplasmic eosinophilic granules, were found in the masses associated with the omentum, stomach, and liver. <i>Salmonella enteritidis</i> was isolated in pure culture from the thoracic fluid, collected during clinical examination, and mesenteric mass, collected during necropsy, and both isolates showed similar antimicrobial susceptibility patterns.

Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors

2019 ◽  
Vol 120 (8) ◽  
pp. 1311-1317 ◽  
Author(s):  
Yosuke Kasai ◽  
Kelly Mahuron ◽  
Kenzo Hirose ◽  
Carlos U. Corvera ◽  
Grace E. Kim ◽  
...  
Keyword(s):  
Neuroendocrine Tumors ◽  
Prognostic Impact ◽  
Mesenteric Mass

Impact of Mesenteric Mass in Patients With Midgut Neuroendocrine Tumors

Pancreas ◽  
2019 ◽  
Vol 48 (5) ◽  
pp. 682-685 ◽  
Author(s):  
Preeti Malik ◽  
Candida Pinto ◽  
Monica S. Naparst ◽  
Stephen C. Ward ◽  
Anne Aronson ◽  
...  
Keyword(s):  
Neuroendocrine Tumors ◽  
Mesenteric Mass

scholarly journals A RARE CASE OF MESENTERIC GASTROINTESTINAL STROMAL TUMOUR (GIST) PRESENTING AS MESENTERIC MASS.

2020 ◽  
pp. 1-2
Author(s):  
Bansil V. Javia ◽  
Hitendra K. Desai ◽  
Neel B. Patel ◽  
Purvesh V. Doshi
Keyword(s):  
Gastrointestinal Tract ◽  
Small Bowel ◽  
Rare Case ◽  
Gastrointestinal Stromal Tumour ◽  
Good Survival ◽  
Incomplete Resection ◽  
Gastrointestinal Stromal Tumours ◽  
Rare Tumours ◽  
High Incidence ◽  
Mesenteric Mass

Gastrointestinal stromal tumours (GIST) are rare tumours arising from mesenchyme of gastrointestinal tract and overexpress C-kit protein. Mainly seen in stomach and small bowel. Mesenteric GIST are rarely reported as they constitute less than 1% of total GIST. We hereby report such a rare case of GIST arising from mesentery of small bowel and presenting as intra-abdominal mesenteric mass. Good surgical clearance ensures good survival whereas incomplete resection results in a high incidence of recurrences with distant metastasis.

Sign in / Sign up

Export Citation Format

Share Document